pubmed-article:20605462 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20605462 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20605462 | lifeskim:mentions | umls-concept:C0041318 | lld:lifeskim |
pubmed-article:20605462 | lifeskim:mentions | umls-concept:C0205494 | lld:lifeskim |
pubmed-article:20605462 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
pubmed-article:20605462 | lifeskim:mentions | umls-concept:C0020029 | lld:lifeskim |
pubmed-article:20605462 | lifeskim:mentions | umls-concept:C0027978 | lld:lifeskim |
pubmed-article:20605462 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
pubmed-article:20605462 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:20605462 | pubmed:dateCreated | 2010-7-30 | lld:pubmed |
pubmed-article:20605462 | pubmed:abstractText | Mortality and serious long-term sequelae still occur in about 50% of patients with tuberculous meningitis. The frequency and the clinical features of neurological and systemic complications were determined in a retrospective review of 104 patients with tuberculous meningitis. Complications occurred in 81 patients (78%). The most common complications were: hyponatraemia 49%, hydrocephalus 42%, stroke 33%, cranial nerve palsies 29%, epileptic seizures 28%, diabetes insipidus 6%, tuberculoma 3%, myeloradiculopathy 3% and hypothalamic syndrome 3%. The most common iatrogenic complication was hepatotoxicity related to anti-tuberculosis treatment in seven patients. Twenty-three patients (22%) died. At last follow-up one patient (1%) remained in a persistent vegetative state, 14 patients (13%) had severe disability and 12 patients (12%) were moderately disabled. The most common complications in the 81 long-term survivors were cognitive impairment (12%) and epilepsy (11%). Neurological and systemic complications of tuberculous meningitis were common and were important causes of mortality and long-term morbidity. | lld:pubmed |
pubmed-article:20605462 | pubmed:language | eng | lld:pubmed |
pubmed-article:20605462 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20605462 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20605462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20605462 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20605462 | pubmed:month | Sep | lld:pubmed |
pubmed-article:20605462 | pubmed:issn | 1532-2653 | lld:pubmed |
pubmed-article:20605462 | pubmed:author | pubmed-author:MasonD FDF | lld:pubmed |
pubmed-article:20605462 | pubmed:author | pubmed-author:HollandDD | lld:pubmed |
pubmed-article:20605462 | pubmed:author | pubmed-author:ThomasM GMG | lld:pubmed |
pubmed-article:20605462 | pubmed:author | pubmed-author:AndersonN ENE | lld:pubmed |
pubmed-article:20605462 | pubmed:author | pubmed-author:SomaratneJJ | lld:pubmed |
pubmed-article:20605462 | pubmed:copyrightInfo | Copyright 2010 Elsevier Ltd. All rights reserved. | lld:pubmed |
pubmed-article:20605462 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20605462 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:20605462 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20605462 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20605462 | pubmed:pagination | 1114-8 | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:meshHeading | pubmed-meshheading:20605462... | lld:pubmed |
pubmed-article:20605462 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20605462 | pubmed:articleTitle | Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand. | lld:pubmed |
pubmed-article:20605462 | pubmed:affiliation | Department of Neurology, Auckland City Hospital, Private Bag 92024, Auckland, New Zealand. neila@adhb.govt.nz | lld:pubmed |
pubmed-article:20605462 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20605462 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:20605462 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |